SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-012959
Filing Date
2021-04-15
Accepted
2021-04-15 17:03:04
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A nt10022735x10_defa14a.htm DEFA14A 15694
2 nt10022735x10_img01.jpg GRAPHIC 36428
3 nt10022735x10_img02.jpg GRAPHIC 11726
4 nt10022735x10_img03.jpg GRAPHIC 16262
5 nt10022735x10_img04.jpg GRAPHIC 31588
6 nt10022735x10_img05.jpg GRAPHIC 36823
  Complete submission text file 0001140361-21-012959.txt   200361
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 21829212
SIC: 2836 Biological Products, (No Diagnostic Substances)